Stay updated with breaking news from Nasdaq Regn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
U.S. Capital Wealth Advisors LLC grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 20.9% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,042 shares of the biopharmaceutical company’s stock after acquiring an additional 180 shares during the quarter. […]
New York State Common Retirement Fund lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 3.6% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 170,177 shares of the biopharmaceutical company’s stock after selling 6,396 shares during the quarter. […]
Samalin Investment Counsel LLC cut its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.3% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 718 shares of the biopharmaceutical company’s stock after selling 40 shares during the quarter. Samalin Investment Counsel […]
Asio Capital LLC increased its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 1.2% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,270 shares of the biopharmaceutical company’s stock after purchasing an additional 27 shares during the quarter. Asio […]
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has received a consensus rating of “Moderate Buy” from the twenty-six ratings firms that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, six have given a hold rating and nineteen have issued a buy rating on the company. […]